Overview

Preventing Recurrent Bleeding After Eradication of Esophageal Varices

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Esophageal variceal bleeding is a severe complication of portal hypertension. Banding ligation plus non-selective beta-blockers is the current recommendation for prevention of recurrent bleeding. However, the optimal duration of use of non-selective beta-blockers is not well defined. This study aims at comparing the rebleeding rate and adverse effects in patients using or without using propranolol after eradication of esophageal varices.
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Treatments:
Propranolol